Predictive Oncology Inc. (POAI) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Axe Compute Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.601 Good day, and thank you for standing by. Welcome to the Predictive Oncology Second Quarter 00:00:04.601 -- 00:00:09.974 2024 Earnings Conference Call. At this time, all participants are in a listen-only 00:00:09.974 -- 00:00:15.076 mode. After the speaker's prepared presentation, there will be an opportunity 00:00:15.076 -- 00:00:17.077 to ask questions. 00:00:17.077 -- 00:00:20.939 Please be advised that today's conference is being recorded. 00:00:20.939 -- 00:00:24.301 I would now like to hand the call over to your speaker, Mr. 00:00:24.301 -- 00:00:27.583 Glenn Garmont, Investor Relations. Thank you. 00:00:27.583 -- 00:00:29.843 You may begin. 00:00:29.915 -- 00:00:33.327 Welcome and thank you, everyone, for dialing into the Predictive Oncology second quarter 00:00:33.327 -- 00:00:34.979 2024 00:00:34.979 -- 00:00:39.762 financial results call. First, you'll hear from our chief executive officer and chairman 00:00:39.762 -- 00:00:44.505 of the board, Raymond Venari, and then our chief financial officer, Josh Blatcher, will 00:00:44.505 -- 00:00:48.688 review our financials. Certain matters discussed on this call contain forward-looking 00:00:48.688 -- 00:00:53.411 statements. These forward-looking statements reflect our current expectations and projections 00:00:53.411 -- 00:00:58.737 about future events and are subject to substantial risks, uncertainties, and assumptions 00:00:58.737 -- 00:01:01.539 about our operations and the investments we make. 00:01:01.539 -- 00:01:05.582 All statements other than statements of historical facts included in the call regarding 00:01:05.582 -- 00:01:10.785 our strategy, future operations, future financial position, future revenue and financial 00:01:10.785 -- 00:01:15.869 performance, project...